Dechra Pharmaceuticals PLC Director/PDMR Shareholding (8974K)

TIDMDPH

RNS Number : 8974K

Dechra Pharmaceuticals PLC

19 December 2018

19 December 2018

Dechra Pharmaceuticals PLC

Notification of Transactions by Persons Discharging Managerial Responsibilities

Dechra Pharmaceuticals PLC has been notified that on 18 December 2018 Tony Griffin, Director, sold 5,000 ordinary shares in the Company at a price of GBP21.1537 each.

Following this disposal, Tony Griffin's beneficial interest in the Company is 70,606 shares (0.069% of the current issued share capital).

The Notification of Dealing Form set out below is provided in accordance with Article 19.3 of MAR.

Notification of Dealing Form:

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                 Tony Griffin 
     -----------------------------------  ---------------------------------- 
 2.   Reason for the notification 
     ----------------------------------------------------------------------- 
 a)   Position/status                      Director 
     -----------------------------------  ---------------------------------- 
 b)   Initial notification/                Initial Notification 
       amendment 
     -----------------------------------  ---------------------------------- 
 3.   Details of the Issuer 
     ----------------------------------------------------------------------- 
 a)   Name                                 Dechra Pharmaceuticals PLC 
     -----------------------------------  ---------------------------------- 
 b)   LEI code                             213800J4UVB5OWG8VX82 
     -----------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ----------------------------------------------------------------------- 
 a)   Description                          Ordinary Shares of 1 pence each 
       of the financial 
       instrument 
                                            ISIN: GB0009633180 
       Identification 
       code 
     -----------------------------------  ---------------------------------- 
 b)   Nature of the                        Sale of Shares 
       transaction 
     -----------------------------------  ---------------------------------- 
 c)   Price(s) and                         Price(s)            Volume(s) 
       volumes(s) 
                                            GBP21.1537          5,000 
     -----------------------------------  ------------------  -------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                             5,000 
 
             *    Price                      GBP21.1537 
                                             GBP105,768.50 
 
             *    Total 
     -----------------------------------  ---------------------------------- 
 e)   Date of the                          18 December 2018 
       transaction 
     -----------------------------------  ---------------------------------- 
 f)   Place of the                         London Stock Exchange 
       transaction 
     -----------------------------------  ---------------------------------- 
 

For further information, please contact:

Melanie Hall, Company Secretary

Dechra Pharmaceuticals PLC

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFKFDQOBDDOBD

(END) Dow Jones Newswires

December 19, 2018 02:00 ET (07:00 GMT)